Clinical trial
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer
NCT04267887
Study timeline
Study start (actual)2020-05-11Date precision: day
Registry last updated2026-07-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Castration-Sensitive Prostate Carcinomaunresolved
Metastatic Prostate Carcinomaunresolved
Stage IVB Prostate Cancer AJCC v8unresolved
Interventions
Abiraterone AcetateDRUG · verified · RxNorm: abiraterone acetate
ApalutamideDRUG · verified · RxNorm: apalutamide
PrednisoneDRUG · verified · RxNorm: prednisone
Computed TomographyPROCEDURE
Bone ScanPROCEDURE
Biospecimen CollectionPROCEDURE
Sponsors & collaborators
OHSU Knight Cancer Institutelead sponsor
Janssen Scientific Affairs, LLCcollaborator
Oregon Health and Science Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04267887 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.